RT Journal Article
T1 ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement.
A1 Faroux, Laurent
A1 Lhermusier, Thibault
A1 Vincent, Flavien
A1 Nombela-Franco, Luis
A1 Tchétché, Didier
A1 Barbanti, Marco
A1 Abdel-Wahab, Mohamed
A1 Windecker, Stephan
A1 Auffret, Vincent
A1 Campanha-Borges, Diego Carter
A1 Fischer, Quentin
A1 Muñoz-Garcia, Erika
A1 Trillo-Nouche, Ramiro
A1 Jorgensen, Troels
A1 Serra, Vicens
A1 Toggweiler, Stefan
A1 Tarantini, Giuseppe
A1 Saia, Francesco
A1 Durand, Eric
A1 Donaint, Pierre
A1 Gutierrez-Ibanes, Enrique
A1 Wijeysundera, Harindra C
A1 Veiga, Gabriela
A1 Patti, Giuseppe
A1 D'Ascenzo, Fabrizio
A1 Moreno, Raul
A1 Hengstenberg, Christian
A1 Chamandi, Chekrallah
A1 Asmarats, Lluis
A1 Hernandez-Antolin, Rosana
A1 Gomez-Hospital, Joan Antoni
A1 Cordoba-Soriano, Juan Gabriel
A1 Landes, Uri
A1 Jimenez-Diaz, Victor Alfonso
A1 Cruz-Gonzalez, Ignacio
A1 Nejjari, Mohammed
A1 Roubille, François
A1 Van Belle, Éric
A1 Armijo, German
A1 Siddiqui, Saifullah
A1 Costa, Giuliano
A1 Elsaify, Sameh
A1 Pilgrim, Thomas
A1 le Breton, Hervé
A1 Urena, Marina
A1 Muñoz-Garcia, Antonio Jesus
A1 Sondergaard, Lars
A1 Bach-Oller, Montserrat
A1 Fraccaro, Chiara
A1 Eltchaninoff, Hélène
A1 Metz, Damien
A1 Tamargo, Maria
A1 Fradejas-Sastre, Victor
A1 Rognoni, Andrea
A1 Bruno, Francesco
A1 Goliasch, Georg
A1 Santaló-Corcoy, Marcelo
A1 Jimenez-Mazuecos, Jesus
A1 Webb, John G
A1 Muntané-Carol, Guillem
A1 Paradis, Jean-Michal
A1 Mangieri, Antonio
A1 Ribeiro, Henrique Barbosa
A1 Campelo-Parada, Francisco
A1 Rodés-Cabau, Josep
K1 ST-segment elevation myocardial infarction
K1 acute coronary syndrome
K1 mortality
K1 percutaneous coronary intervention
K1 transcatheter aortic valve replacement
AB Among patients with acute coronary syndrome following transcatheter aortic valve replacement (TAVR), those presenting with ST-segment elevation myocardial infarction (STEMI) are at highest risk. The goal of this study was to determine the clinical characteristics, management, and outcomes of STEMI after TAVR. This was a multicenter study including 118 patients presenting with STEMI at a median of 255 days (interquartile range: 9 to 680 days) after TAVR. Procedural features of STEMI after TAVR managed with primary percutaneous coronary intervention (PCI) were compared with all-comer STEMI: 439 non-TAVR patients who had primary PCI within the 2 weeks before and after each post-TAVR STEMI case in 5 participating centers from different countries. Median door-to-balloon time was higher in TAVR patients (40 min [interquartile range: 25 to 57 min] vs. 30 min [interquartile range: 25 to 35 min]; p = 0.003). Procedural time, fluoroscopy time, dose-area product, and contrast volume were also higher in TAVR patients (p  STEMI after TAVR was associated with very high in-hospital and mid-term mortality. Longer door-to-balloon times and a higher PCI failure rate were observed in TAVR patients, partially due to coronary access issues specific to the TAVR population, and this was associated with poorer outcomes.
YR 2021
FD 2021
LK http://hdl.handle.net/10668/17727
UL http://hdl.handle.net/10668/17727
LA en
DS RISalud
RD Apr 6, 2025